Getting Biosimilars to Market: A Virtual Panel Discussion
Getting Biosimilars to Market: A Virtual Panel Discussion
Getting Biosimilars to Market, a recent virtual panel moderated by MoginRubin’s Joy Sidhwa, examines commercial challenges facing biosimilars from both the patent and the antitrust…
FTC, States Agree on Path Forward for Amgen’s Horizon Therapeutics Deal
Settlement said to resolve anticompetitive concerns over critical drugs. The Federal Trade Commission and attorneys general from six states – California, Illinois, Minnesota, New York,…
Pharma: Consumer Groups, States Support Reviving Generic Drugs Antitrust Case Against AbbVie
Pro-consumer organizations — Consumer Action and U.S. Public Interest Research Group — and 20 states have filed amici curiae briefs with the Seventh Circuit U.S.…